PT Pyridam Farma Tbk PT Pyridam Farma Tbk

PT Pyridam Farma Tbk

PYFA

Rank in Stocks #20303
PT Pyridam Farma Tbk, an Indonesian-based enterprise, specializes in the... PT Pyridam Farma Tbk, an Indonesian-based enterprise, specializes in the development, production, and distribution of a broad spectrum of health-related products. Its offerings encompass pharmaceuticals, antibiotics, essential vitamins, dietary supplements, and traditional herbal remedies. The company's operations are divided into two main segments: Pharmaceutical Products and Contract Manufacturing Services, and Medical Device Products. Within its medical device division, the firm provides a variety of instruments and consumables. These include clinical waste management items, collection swabs and tubes, innerbox DCA, KF94 masks, parafilm, PCR extraction kits and their accompanying machinery, specimen bags, sterile containers, and tube stoppers. Furthermore, PT Pyridam Farma markets a diverse collection of skincare products, such as Arosa gel, A-Stark Gel, Hymen gel, Pyderen Emulsion, Tonic Bust Emulsion, Calmosan Cream, and Di-Herb gel. Its pharmaceutical portfolio addresses numerous therapeutic areas, including digestive and metabolic health, blood and blood-forming organ conditions, cardiovascular disorders, dermatological ailments, genitourinary system and sex hormone regulation, systemic corticosteroids, systemic antibacterial treatments, sensory organ issues, as well as musculoskeletal, nervous, and respiratory system conditions. Beyond medicinal lines, the company also develops and sells dietary supplements and preventive consumer health items, notably energy drinks and various healthy ready-to-consume beverages. A key area of its strategic focus involves conducting extensive research and development in biotechnology, life sciences, and medical science. Established in 1976, PT Pyridam Farma Tbk is headquartered in Jakarta, Indonesia.
Share Price
$0.00734834
Last synced: 2026-11-16
Market Cap
$82.57M
Change (1 day)
-3.58%
Change (1 year)
-76.44%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
Revenue for PT Pyridam Farma Tbk (PYFA)
Revenue in Sep 2026 TTM: $170.82M
According to PT Pyridam Farma Tbk's latest financial reports, its current revenue (TTM) is $170.82M. In 2025 the company's revenue was $165.35M, an increase over its 2024 revenue of $118.42M. Revenue is the total income a company makes from selling goods or services; unlike earnings, no expenses are subtracted.
Revenue history for PT Pyridam Farma Tbk from 2005 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $170.82M 3.30%
2025 $165.35M 39.64%
2024 $118.42M 159.58%
2023 $45.62M -0.92%
2022 $46.04M 4.00%
2021 $44.27M 122.74%
2020 $19.88M 11.75%
2019 $17.79M 2.76%
2018 $17.31M 5.27%
2017 $16.44M 2.08%
2016 $16.11M 2.09%
2015 $15.78M -11.86%
2014 $17.90M 13.21%
2013 $15.81M -13.72%
2012 $18.32M 9.97%
2011 $16.66M 6.33%
2010 $15.67M 11.95%
2009 $14.00M 29.01%
2008 $10.85M 17.75%
2007 $9.21M 35.84%
2006 $6.78M 67.99%
2005 $4.04M 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$23.37B 13,579.99%
DE
$23.30B 13,539.23%
DE
$29.38B 17,101.49%
JP
$5.85B 3,323.96%
CH
$17.41B 10,094.06%
IL

Questions about PT Pyridam Farma Tbk's revenue

What is PT Pyridam Farma Tbk's revenue?

PT Pyridam Farma Tbk's revenue over the last twelve months is $170.82M, as of Sep 2026.

What was PT Pyridam Farma Tbk's revenue in 2025?

In 2025, PT Pyridam Farma Tbk's revenue was $165.35M, 39.64% more than in 2024 ($118.42M).

How has PT Pyridam Farma Tbk's revenue changed since 2020?

From 2020 to 2025, PT Pyridam Farma Tbk's revenue went from $19.88M to $165.35M, an average growth of 52.76% a year.

How does PT Pyridam Farma Tbk's revenue compare with similar companies?

PT Pyridam Farma Tbk's revenue ($170.82M) is lower than that of all 5 similar companies listed above. The highest among them is Takeda Pharmaceutical Company Limited, with $29.38B.